Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes

• Status: Completed
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This observational study is conducted in Europe. The trial aims to observe the incidence of serious adverse drug reactions in children and adolescents with type 1 diabetes during Levemir® treatment.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin Detemir

Criteria

Inclusion Criteria:

• Informed consent obtained prior to any trial-related activities

• Any patient with diabetes type 1 is eligible for the study, including newly

• The selection of the patients will be at the discretion of the individual physician

Exclusion Criteria:

• Type 2 diabetes

• Currently treated with Levemir®